Latest news
Gilead Earnings: HIV Prevention Market Growth Drives Strong Quarter, Maintaining Our Fair Value - MorningstarMorningstar · Wed, 05 Aug 2026 08:12:06 GMTAmgen Earnings: Broad-Based Growth Despite Prolia Biosimilars; Maintaining Our Fair Value - MorningstarMorningstar · Wed, 05 Aug 2026 06:56:12 GMTGilead's Steady Long-Term Growth Prospects in HIV and Expansion in Oncology Support a Wide Moat - MorningstarMorningstar · Wed, 05 Aug 2026 05:06:10 GMTAbbVie's Skyrizi and Rinvoq Launches Support Lengthy Patent Protection and a Wide Moat - MorningstarMorningstar · Fri, 31 Jul 2026 22:40:08 GMTMicrosoft Earnings: Azure Accelerates While Capital Expenditure Guidance Is Steady - MorningstarMorningstar · Thu, 30 Jul 2026 08:54:26 GMTMicrosoft: What We Think of the Stock After Earnings - MorningstarMorningstar · Thu, 30 Jul 2026 07:00:00 GMTBAE Systems: What We Think of the Stock After Earnings. - MorningstarMorningstar · Thu, 30 Jul 2026 07:00:00 GMTTransUnion Results: Encouraging Quarter; Maintaining Our $85 Fair Value Estimate - MorningstarMorningstar · Tue, 28 Jul 2026 20:40:16 GMT